FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2059492063> ?p ?o ?g. }

• W2059492063 endingPage "53" @default.
• W2059492063 startingPage "48" @default.
• W2059492063 abstract "Abstract Treatment of mantle cell lymphoma (MCL) in younger patients remains a challenge. We report results of a phase 2 trial using cytarabine and rituximab as induction regimen before autologous stem cell transplantation. Patients younger than 66 years with stage 3 or 4 MCL were included. Treatment consisted of 3 courses of CHOP21 with rituximab at the third one and 3 of R-DHAP. Responding patients were eligible for autologous stem cell transplantation with TAM6 or BEAM. Sixty patients were included. Median age was 57 years. Characteristics of patients were: BM involvement 85%, leukemic disease 48%, gastrointestinal involvement 52%, Performance Status > 16%, lactate dehydrogenase > 1N 38%, Mantle Cell Lymphoma International Prognostic Index (low 55%, intermediate 38%, high 13%). The overall response rate was 93% after (R)-CHOP and 95% after R-DHAP. Although uncommon after (R)-CHOP (12%), 57% of patients were in complete response after R-DHAP. With median follow-up of 67 months, median event-free survival is 83 months, and median overall survival is not reached. Five-year overall survival is 75%. Comparison with a previous study without rituximab shows improvement of outcome (median event-free survival, 51 vs 83 months). No toxic death or unexpected toxicities were observed. This study confirms that induction with rituximab and cytarabine-based regimens is safe and effective in MCL patients. This regimen is currently compared with R-CHOP21 induction in a multicentric European protocol." @default.
• W2059492063 created "2016-06-24" @default.
• W2059492063 creator A5003078312 @default.
• W2059492063 creator A5011643510 @default.
• W2059492063 creator A5019759127 @default.
• W2059492063 creator A5028371625 @default.
• W2059492063 creator A5031041032 @default.
• W2059492063 creator A5032462496 @default.
• W2059492063 creator A5054828210 @default.
• W2059492063 creator A5056514957 @default.
• W2059492063 creator A5062305482 @default.
• W2059492063 creator A5067560032 @default.
• W2059492063 creator A5086354986 @default.
• W2059492063 creator A5088509972 @default.
• W2059492063 date "2013-01-03" @default.
• W2059492063 modified "2023-10-12" @default.
• W2059492063 title "CHOP and DHAP plus rituximab followed by autologous stem cell transplantation in mantle cell lymphoma: a phase 2 study from the Groupe d'Etude des Lymphomes de l'Adulte" @default.
• W2059492063 cites W1912693401 @default.
• W2059492063 cites W1945251789 @default.
• W2059492063 cites W1994161738 @default.
• W2059492063 cites W1997671124 @default.
• W2059492063 cites W2041423582 @default.
• W2059492063 cites W2041879310 @default.
• W2059492063 cites W2070698509 @default.
• W2059492063 cites W2090403252 @default.
• W2059492063 cites W2107514820 @default.
• W2059492063 cites W2107804586 @default.
• W2059492063 cites W2111509717 @default.
• W2059492063 cites W2123236288 @default.
• W2059492063 cites W2124235514 @default.
• W2059492063 cites W2125684345 @default.
• W2059492063 cites W2151092645 @default.
• W2059492063 cites W2162109567 @default.
• W2059492063 cites W2163790170 @default.
• W2059492063 cites W4255357812 @default.
• W2059492063 doi "https://doi.org/10.1182/blood-2011-09-370320" @default.
• W2059492063 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22718839" @default.
• W2059492063 hasPublicationYear "2013" @default.
• W2059492063 type Work @default.
• W2059492063 sameAs 2059492063 @default.
• W2059492063 citedByCount "230" @default.
• W2059492063 countsByYear W20594920632012 @default.
• W2059492063 countsByYear W20594920632013 @default.
• W2059492063 countsByYear W20594920632014 @default.
• W2059492063 countsByYear W20594920632015 @default.
• W2059492063 countsByYear W20594920632016 @default.
• W2059492063 countsByYear W20594920632017 @default.
• W2059492063 countsByYear W20594920632018 @default.
• W2059492063 countsByYear W20594920632019 @default.
• W2059492063 countsByYear W20594920632020 @default.
• W2059492063 countsByYear W20594920632021 @default.
• W2059492063 countsByYear W20594920632022 @default.
• W2059492063 countsByYear W20594920632023 @default.
• W2059492063 crossrefType "journal-article" @default.
• W2059492063 hasAuthorship W2059492063A5003078312 @default.
• W2059492063 hasAuthorship W2059492063A5011643510 @default.
• W2059492063 hasAuthorship W2059492063A5019759127 @default.
• W2059492063 hasAuthorship W2059492063A5028371625 @default.
• W2059492063 hasAuthorship W2059492063A5031041032 @default.
• W2059492063 hasAuthorship W2059492063A5032462496 @default.
• W2059492063 hasAuthorship W2059492063A5054828210 @default.
• W2059492063 hasAuthorship W2059492063A5056514957 @default.
• W2059492063 hasAuthorship W2059492063A5062305482 @default.
• W2059492063 hasAuthorship W2059492063A5067560032 @default.
• W2059492063 hasAuthorship W2059492063A5086354986 @default.
• W2059492063 hasAuthorship W2059492063A5088509972 @default.
• W2059492063 hasBestOaLocation W20594920631 @default.
• W2059492063 hasConcept C126322002 @default.
• W2059492063 hasConcept C141071460 @default.
• W2059492063 hasConcept C143998085 @default.
• W2059492063 hasConcept C181199279 @default.
• W2059492063 hasConcept C2776694085 @default.
• W2059492063 hasConcept C2777525834 @default.
• W2059492063 hasConcept C2778041864 @default.
• W2059492063 hasConcept C2778476033 @default.
• W2059492063 hasConcept C2779050716 @default.
• W2059492063 hasConcept C2779338263 @default.
• W2059492063 hasConcept C2779617269 @default.
• W2059492063 hasConcept C2779725641 @default.
• W2059492063 hasConcept C2780653079 @default.
• W2059492063 hasConcept C2781413609 @default.
• W2059492063 hasConcept C2911091166 @default.
• W2059492063 hasConcept C55493867 @default.
• W2059492063 hasConcept C71924100 @default.
• W2059492063 hasConcept C86803240 @default.
• W2059492063 hasConcept C90924648 @default.
• W2059492063 hasConceptScore W2059492063C126322002 @default.
• W2059492063 hasConceptScore W2059492063C141071460 @default.
• W2059492063 hasConceptScore W2059492063C143998085 @default.
• W2059492063 hasConceptScore W2059492063C181199279 @default.
• W2059492063 hasConceptScore W2059492063C2776694085 @default.
• W2059492063 hasConceptScore W2059492063C2777525834 @default.
• W2059492063 hasConceptScore W2059492063C2778041864 @default.
• W2059492063 hasConceptScore W2059492063C2778476033 @default.
• W2059492063 hasConceptScore W2059492063C2779050716 @default.
• W2059492063 hasConceptScore W2059492063C2779338263 @default.
• W2059492063 hasConceptScore W2059492063C2779617269 @default.
• W2059492063 hasConceptScore W2059492063C2779725641 @default.

• next